{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-03T12:25:32.193448+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals (VRTX): Revisiting Valuation After Upbeat Earnings Revisions and Growth Forecasts - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQdjZTaWMyRDNVNVFSOWRUMkh6M2xZOGpYQUxWV0l6em5CNG5JUm8tUGdVbDdCWVAycGxWRHVzc0xwQzRVVWFmM0NFZERtaEdsR1JVbnFGMGNNbThvV2gtSHlNX294WVlFNUo4bXl4VGk2WGx5UlpaSGI0bDNXRmFRbHJPblBGc3pXUm43YmFwa1VlNFhFUmpPdnFYX1ZueU9NLVUyYkVyaHBZblhtNGNQLVJVSG9WNllBeGNJT2xzUDBDWnFoT0ZfSG94MV90YXRlcm5fODZjdFdzNlA4dDlmTkxvNVBXNi13OGtMYi12bWNXQdIB8gFBVV95cUxQdjZTaWMyRDNVNVFSOWRUMkh6M2xZOGpYQUxWV0l6em5CNG5JUm8tUGdVbDdCWVAycGxWRHVzc0xwQzRVVWFmM0NFZERtaEdsR1JVbnFGMGNNbThvV2gtSHlNX294WVlFNUo4bXl4VGk2WGx5UlpaSGI0bDNXRmFRbHJPblBGc3pXUm43YmFwa1VlNFhFUmpPdnFYX1ZueU9NLVUyYkVyaHBZblhtNGNQLVJVSG9WNllBeGNJT2xzUDBDWnFoT0ZfSG94MV90YXRlcm5fODZjdFdzNlA4dDlmTkxvNVBXNi13OGtMYi12bWNXQQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Revisiting Valuation After Upbeat Earnings Revisions and Growth Forecasts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-03T10:32:22+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPRU1LQUJsWDBlTHpDTFU3ZFVYblkyZnBQZXNoMV9BOUNURng2a3BFbmxpejdaU29hcmN6VFlfaHdEZmRHZ21iaHhxWm83ZXBwNUpGajlNOGpZT1RMcDYwWlVBOW0wVFMySzBMdTJtRlh5QVQ2anR6czFvU2ZGMFBGN2dIeXpYUDRPTHZmY0U2ZjloQzkzODBz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxPRU1LQUJsWDBlTHpDTFU3ZFVYblkyZnBQZXNoMV9BOUNURng2a3BFbmxpejdaU29hcmN6VFlfaHdEZmRHZ21iaHhxWm83ZXBwNUpGajlNOGpZT1RMcDYwWlVBOW0wVFMySzBMdTJtRlh5QVQ2anR6czFvU2ZGMFBGN2dIeXpYUDRPTHZmY0U2ZjloQzkzODBz?oc=5\" target=\"_blank\">1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-17T08:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5\" target=\"_blank\">Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-12-03T10:28:02+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Morgan Stanley Upgrades Vertex Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $516 From $438 - MarketScreener",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYVZ1eUU2YTMweXliNnNjV3o1V1RublFEWDZJQnl2eV9fRkFVWmdjSVY5V1N2QWJFcHNrSGMzcnpuQ2pONzdDQmkyaWJOLW1vQU5rVnFla0FiV3pJSndnN0RVMENkUEQ1ZUZCMW43MkFIMGJRdTdWWlZ4TU9lVzZoVUU5ZzhFczNiOHhTcUNuYjBObUc1R1VSbjJkU1M5b3VZRkN0VHFVYnpGZlU1elJmRXVoTnlma1A1UHVBT2tqMldTcFFNWmhvSlUzVEJTV0dIdXRvM3o4bFJZZVVneS1LRmxLWnpDdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYVZ1eUU2YTMweXliNnNjV3o1V1RublFEWDZJQnl2eV9fRkFVWmdjSVY5V1N2QWJFcHNrSGMzcnpuQ2pONzdDQmkyaWJOLW1vQU5rVnFla0FiV3pJSndnN0RVMENkUEQ1ZUZCMW43MkFIMGJRdTdWWlZ4TU9lVzZoVUU5ZzhFczNiOHhTcUNuYjBObUc1R1VSbjJkU1M5b3VZRkN0VHFVYnpGZlU1elJmRXVoTnlma1A1UHVBT2tqMldTcFFNWmhvSlUzVEJTV0dIdXRvM3o4bFJZZVVneS1LRmxLWnpDdw?oc=5\" target=\"_blank\">Morgan Stanley Upgrades Vertex Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $516 From $438</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>",
      "published": "2025-12-03T10:22:45+00:00",
      "source": "MarketScreener"
    },
    {
      "title": "Vertex Pharmaceuticals Stock: Analyst Estimates & Ratings - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPWE9vZkFtM3pselZGc0NNNXd6TGhrSnhzLWt3RDNPLWkyU2xqbklmR3RLbmpsR3V1d1lOMTZsVW13VGgyRVJXb1FqQ1dUcDFwU19DMXRmT21ReS1mSl9aQW9SOHA3S2lQUXBEdHFuc21KME1Zd2NiMnpyeFhzQk5NcnJsNzNVVExoSUtQbk5HdUZhbjQ4N2dz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxPWE9vZkFtM3pselZGc0NNNXd6TGhrSnhzLWt3RDNPLWkyU2xqbklmR3RLbmpsR3V1d1lOMTZsVW13VGgyRVJXb1FqQ1dUcDFwU19DMXRmT21ReS1mSl9aQW9SOHA3S2lQUXBEdHFuc21KME1Zd2NiMnpyeFhzQk5NcnJsNzNVVExoSUtQbk5HdUZhbjQ4N2dz?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock: Analyst Estimates & Ratings</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-18T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq? - Barchart.com",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barchart.com</font>",
      "published": "2025-11-28T11:25:04+00:00",
      "source": "Barchart.com"
    },
    {
      "title": "Akeso’s Goals Beyond Ivonescimab: ‘We Can Hit Vertex And Regeneron-Level Innovation’ - Citeline News & Insights",
      "link": "https://news.google.com/rss/articles/CBMi_AFBVV95cUxPaUltNmRkTUtnTC11VEgzUkhiSnZyVnpqbFNzZ09fOU5GTlBTM2RKdDIzOHJVVDduY0p1ckl1VnpGOHVZQW9kYlZfbUVGM3ZWMGNTWkdxUUFyTEVDLWRoLXI1b1RnT29MMmxIWWtjSkx4WkcwbXN0dnY2Zkg3QjRJWTRCMVl6T0hYNEpDSzhUWDlRU19wNFdCWDBCU3N5ajN5QTNYQ0VMb202R3VQR2wtcjhwcy14UzRxOWdqQXI0VzF6REhLQndjT1VOWC1lYURHcy1Ray15bmJPQ0h6R19PSWlPbi1NVkdnTnZHMjFRZHA1TDdJQXh1MkhaX3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPaUltNmRkTUtnTC11VEgzUkhiSnZyVnpqbFNzZ09fOU5GTlBTM2RKdDIzOHJVVDduY0p1ckl1VnpGOHVZQW9kYlZfbUVGM3ZWMGNTWkdxUUFyTEVDLWRoLXI1b1RnT29MMmxIWWtjSkx4WkcwbXN0dnY2Zkg3QjRJWTRCMVl6T0hYNEpDSzhUWDlRU19wNFdCWDBCU3N5ajN5QTNYQ0VMb202R3VQR2wtcjhwcy14UzRxOWdqQXI0VzF6REhLQndjT1VOWC1lYURHcy1Ray15bmJPQ0h6R19PSWlPbi1NVkdnTnZHMjFRZHA1TDdJQXh1MkhaX3c?oc=5\" target=\"_blank\">Akeso’s Goals Beyond Ivonescimab: ‘We Can Hit Vertex And Regeneron-Level Innovation’</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Citeline News & Insights</font>",
      "published": "2025-12-02T18:02:12+00:00",
      "source": "Citeline News & Insights"
    },
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOakVocm54QUVVNDBTQkNHYU9MSFFIaE1UOWlpMnhUZlBwbXVPTWIxUEduWlZ6aC13eXJOS3BPLWszcmt1b0QzZVBYZUJQcmstcmgtRFdtRFlZcVIzX1ZCOEI3VERmaXkySlNubTZWSnZ2c1lfOWhIX01HQjhXa3daXzd3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOakVocm54QUVVNDBTQkNHYU9MSFFIaE1UOWlpMnhUZlBwbXVPTWIxUEduWlZ6aC13eXJOS3BPLWszcmt1b0QzZVBYZUJQcmstcmgtRFdtRFlZcVIzX1ZCOEI3VERmaXkySlNubTZWSnZ2c1lfOWhIX01HQjhXa3daXzd3?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-11-27T11:31:00+00:00",
      "source": "Nasdaq"
    }
  ],
  "product_launches": [
    {
      "title": "Published on: 2025-12-02 23:32:41 - Newser",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOWERqNTB4dHh6cF9wWUlPbE1DMnRlWlBVdEdIOF94VEFYRU9tbUNkVlJIYkMwVWxFSW9NZW0wY3VTSGtVUG8tNjVKSEFWMVlVekFZVlpyV0V5NFNnLXIyV05zMzFNZDNuZzNDenEtTnJkc3VMODhCNXFhc1BVa3Q5MDB1UnQ0cy1IUEswV3M1aHNjYTBNdkZXVy1famdwNkd4RHc5YnZn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxOWERqNTB4dHh6cF9wWUlPbE1DMnRlWlBVdEdIOF94VEFYRU9tbUNkVlJIYkMwVWxFSW9NZW0wY3VTSGtVUG8tNjVKSEFWMVlVekFZVlpyV0V5NFNnLXIyV05zMzFNZDNuZzNDenEtTnJkc3VMODhCNXFhc1BVa3Q5MDB1UnQ0cy1IUEswV3M1aHNjYTBNdkZXVy1famdwNkd4RHc5YnZn?oc=5\" target=\"_blank\">Published on: 2025-12-02 23:32:41</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-12-03T05:32:41+00:00",
      "source": "Newser"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-02",
      "close": 433.1499938964844
    },
    "history": [
      {
        "date": "2025-11-21",
        "close": 426.760009765625
      },
      {
        "date": "2025-11-24",
        "close": 424.0
      },
      {
        "date": "2025-11-25",
        "close": 429.82000732421875
      },
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      },
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      },
      {
        "date": "2025-12-02",
        "close": 433.1499938964844
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}